CXCL8 and psoriasis: This hypothesis is supported by previous studies; for example, the S100A8/A9 complex is significantly elevated in psoriasis serum and positively correlates with disease activity [85], while CXCL8 inhibitors can significantly reduce intestinal inflammation in animal models [86].